Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - Phio Pharmaceuticals Corp. | d108245dex321.htm |
10-K - FORM 10-K - Phio Pharmaceuticals Corp. | d108245d10k.htm |
EX-31.1 - EX-31.1 - Phio Pharmaceuticals Corp. | d108245dex311.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
RXi Pharmaceuticals Corporation
Marlborough, Massachusetts
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-183633) of RXi Pharmaceuticals Corporation of our report dated March 30, 2016, relating to the financial statements, which appear in this Form 10-K.
/s/ BDO USA, LLP
Boston, Massachusetts
March 30, 2016